|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Operating expenses: | |||||
| Operating expenses (including stock-based compensation of $52,145 in 2024 and $31,415 in 2025 and excluding depreciation and amortization shown separately below) | |||||
| Corporate expenses (including stock-based compensation of $841,147 in 2024 and $171,387 in 2025) | |||||
| Depreciation and amortization | |||||
| Impairment losses | |||||
| Goodwill impairment losses | |||||
| Other impairment losses | |||||
| Gain on exchange | |||||
| Other operating expenses | |||||
| Extinguishment of franchise fee | |||||
| Gain on disposition | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Non-operating income (expense): | |||||
| Interest expense | |||||
| Debt issuance expenses | |||||
| Gain on sale of investment | |||||
| Gain on repurchases of long-term debt | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Loss before equity in earnings of unconsolidated affiliates | |||||
| Equity in earnings of unconsolidated affiliates, net of tax | |||||
| Net loss | |||||
| Net loss attributable to BBGI stockholders | |||||
| Other comprehensive gain (loss): | |||||
| Unrecognized actuarial gain (loss) on postretirement plan (net of income tax expense of $142,846 in 2024 and income tax benefit of $57,303 in 2025) | |||||
| Other comprehensive gain (loss): | |||||
| Net loss per Class A and B common share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...